Moreover, we found that CDCA8 not only had significant clinical correlations with important clinical features of glioma patients, including WHO grade, IDH status, and 1p/19q codeletion, but also had good diagnostic efficacy. This evidence concerns the gene CDCA8 and central nervous system cancer.